Fujifilm Launches 128-Slice Computed Tomography System, FCT iStream, with Vision Modeling Iterative Reconstruction
June 25 2024 - 6:15AM
FUJIFILM Healthcare Americas Corporation, a leading provider of
diagnostic and enterprise imaging solutions, announced it has
received FDA 510(k) clearance for its new compact, 128-slice
computed tomography (CT) system, the FCT iStream. The system
employs four core proprietary Fujifilm technologies, including
HiMAR Plus (High image quality Metal Artifact Reduction), Intelli
IPV, SynergyDrive and IntelliODM to enhance the sharpness of
images, streamline workflow through AI automation, and
significantly reduce patient dose.
There is a clear need to decrease patient radiation dose as much
as possible during imaging, including CT scans. The FCT iStream CT
system comes equipped with several technologies that drive down
patient dose, including Fujifilm’s IntelliODM, an-organ based dose
modulation reduction technique which modulates radiation dose in
angular and/or slice directions based on patient attenuation.
Additionally, Fujifilm’s IntelliEC feature helps further reduce
patient dose for all CT scanning, including cardiac imaging.
Intelli IPV, Fujifilm’s proprietary iterative progressive
reconstruction with visual modeling (IPV) method, is another
innovative technology that enhances sharpness by reducing noise by
up to 90% and provides up to 83% reduced patient
dose.*
To streamline technologist workflow, the system captures 60
images per second and leverages Fujifilm’s SynergyDrive technology
to automate, simplify and accelerate the scanning process.
SynergyDrive helps streamline the entire image capture process,
assisting with automating positioning of the patient inside the CT
system, mapping imaging parameters on where to scan, and scanning
and archiving the images.
“Staff shortages, increased financial pressure and escalating
patient demand are driving radiology departments to look for ways
to streamline workflow, avoid repeat scans and ensure they are
maximizing throughput,” said Shawn Etheridge, executive director,
modality solutions, FUJIFILM Healthcare Americas Corporation.
“We’ve designed FCT iStream to reduce the pain points these
high-volume departments face by engineering an intelligent,
reliable, imaging solution that will help automate clinician’s most
time-consuming steps.”
Scanning patients with metal implants can distort CT images,
making it difficult to clearly visualize details in and around
them. To help clinicians obtain clear, high-quality images for
patients with metal implants, FCT iStream leverages HiMAR Plus
(High image quality Metal Artifact Reduction) technology to detect
and correct corrupted data from the metal in the images. Unlike
traditional methods, it combines both projection-based and
image-based correction. This results in improved image quality
throughout the anatomy, while clarifying metal implants and
surrounding tissue.
To learn more about the FCT iStream, please visit the product
page.
* Iterative Reconstruction Intelli IPV
About Fujifilm
FUJIFILM Healthcare Americas Corporation is a comprehensive
healthcare company that has an extensive range of technology and
expertise in the detection, diagnosis, and treatment of diseases.
Fujifilm’s innovative portfolio includes solutions spanning
diagnostic imaging, enterprise imaging, endoscopic imaging,
surgical imaging, and in-vitro diagnostics. The company is
headquartered in Lexington, Massachusetts. For more information,
please visit healthcaresolutions-us.fujifilm.com.
FUJIFILM Holdings Corporation, headquartered in Tokyo, leverages
its depth of knowledge and proprietary core technologies to deliver
innovative products and services across the globe through the four
key business segments of healthcare, electronics, business
innovation, and imaging with over 70,000 employees. Guided and
united by our Group Purpose of “giving our world more smiles,” we
address social challenges and create a positive impact on society
through our products, services, and business operations. Under its
medium-term management plan, VISION2030, which ends in FY2030, we
aspire to continue our evolution into a company that creates value
and smiles for various stakeholders as a collection of global
leading businesses and achieve a global revenue of 4 trillion yen
(29 billion USD at an exchange rate of 140 JPY/USD). For more
information, please visit:
www.fujifilmholdings.com.
For further details about our commitment to sustainability and
Fujifilm’s Sustainable Value Plan 2030, click here.
Marissa Confredo
FUJIFILM Holdings America Corporation
914-343-4761
marissa.confredo@fujifilm.com